239 related articles for article (PubMed ID: 30661282)
21. A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa.
Amougou MA; Noah DN; Moundipa PF; Pineau P; Njouom R
BMC Infect Dis; 2016 Nov; 16(1):647. PubMed ID: 27821080
[TBL] [Abstract][Full Text] [Related]
22. Risk of liver cirrhosis and hepatocellular carcinoma in subjects with hepatitis B and delta virus infection: a study from Kure, Japan.
Tamura I; Kurimura O; Koda T; Ichimura H; Katayama S; Kurimura T; Inaba Y
J Gastroenterol Hepatol; 1993; 8(5):433-6. PubMed ID: 8218990
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis delta-associated mortality in HIV/HBV-coinfected patients.
Béguelin C; Moradpour D; Sahli R; Suter-Riniker F; Lüthi A; Cavassini M; Günthard HF; Battegay M; Bernasconi E; Schmid P; Calmy A; Braun DL; Furrer H; Rauch A; Wandeler G;
J Hepatol; 2017 Feb; 66(2):297-303. PubMed ID: 27746337
[TBL] [Abstract][Full Text] [Related]
24. Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.
Jang TY; Wei YJ; Liu TW; Yeh ML; Liu SF; Hsu CT; Hsu PY; Lin YH; Liang PC; Hsieh MH; Ko YM; Tsai YS; Chen KY; Lin CC; Tsai PC; Wang SC; Huang CI; Lin ZY; Chen SC; Chuang WL; Huang JF; Dai CY; Huang CF; Yu ML
Sci Rep; 2021 Apr; 11(1):8184. PubMed ID: 33854160
[TBL] [Abstract][Full Text] [Related]
25. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study.
Marcon PDS; Tovo CV; Kliemann DA; Fisch P; de Mattos AA
World J Gastroenterol; 2018 Feb; 24(5):613-622. PubMed ID: 29434450
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis delta infection among persons living with HIV in Europe.
Béguelin C; Atkinson A; Boyd A; Falconer K; Kirkby N; Suter-Riniker F; Günthard HF; Rockstroh JK; Mocroft A; Rauch A; Peters L; Wandeler G;
Liver Int; 2023 Apr; 43(4):819-828. PubMed ID: 36625770
[TBL] [Abstract][Full Text] [Related]
27. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.
Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M
Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358
[TBL] [Abstract][Full Text] [Related]
28. Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study.
Lunel-Fabiani F; Mansour W; Amar AO; Aye M; Le Gal F; Malick FZ; Baïdy L; Brichler S; Veillon P; Ducancelle A; Gordien E; Rosenheim M
J Infect; 2013 Nov; 67(5):448-57. PubMed ID: 23796871
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries.
Razavi HA; Buti M; Terrault NA; Zeuzem S; Yurdaydin C; Tanaka J; Aghemo A; Akarca US; Al Masri NM; Alalwan AM; Aleman S; Alghamdi AS; Alghamdi S; Al-Hamoudi WK; Aljumah AA; Altraif IH; Asselah T; Ben-Ari Z; Berg T; Biondi MJ; Blach S; Braga WSM; Brandão-Mello CE; Brunetto MR; Cabezas J; Cheinquer H; Chen PJ; Cheon ME; Chuang WL; Coffin CS; Coppola N; Craxi A; Crespo J; De Ledinghen V; Duberg AS; Etzion O; Ferraz MLG; Ferreira PRA; Forns X; Foster GR; Gaeta GB; Gamkrelidze I; García-Samaniego J; Gheorghe LS; Gholam PM; Gish RG; Glenn J; Hercun J; Hsu YC; Hu CC; Huang JF; Janjua N; Jia J; Kåberg M; Kaita KDE; Kamal H; Kao JH; Kondili LA; Lagging M; Lázaro P; Lazarus JV; Lee MH; Lim YS; Marotta PJ; Navas MC; Naveira MCM; Orrego M; Osiowy C; Pan CQ; Pessoa MG; Raimondo G; Ramji A; Razavi-Shearer DM; Razavi-Shearer K; Ríos-Hincapié CY; Rodríguez M; Rosenberg WMC; Roulot DM; Ryder SD; Safadi R; Sanai FM; Santantonio TA; Sarrazin C; Shouval D; Tacke F; Tergast TL; Villalobos-Salcedo JM; Voeller AS; Yang HI; Yu ML; Zuckerman E;
J Hepatol; 2023 Aug; 79(2):576-580. PubMed ID: 37030400
[TBL] [Abstract][Full Text] [Related]
30. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
[TBL] [Abstract][Full Text] [Related]
31. New epidemiology of hepatitis delta.
Vlachogiannakos J; Papatheodoridis GV
Liver Int; 2020 Feb; 40 Suppl 1():48-53. PubMed ID: 32077599
[TBL] [Abstract][Full Text] [Related]
32. The medical impact of hepatitis D virus infection in Uzbekistan.
Khodjaeva M; Ibadullaeva N; Khikmatullaeva A; Joldasova E; Ismoilov U; Colombo M; Caviglia GP; Rizzetto M; Musabaev E
Liver Int; 2019 Nov; 39(11):2077-2081. PubMed ID: 31505080
[TBL] [Abstract][Full Text] [Related]
33. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
34. Elevated serum β2-microglobulin in individuals coinfected with hepatitis B and hepatitis D virus in a rural settings in Southwest Nigeria.
Okoror LE; Ajayi AO; Ijalana OB
BMC Res Notes; 2017 Dec; 10(1):719. PubMed ID: 29221492
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: Prevalence and clinical features.
Makhlouf NA; Morsy KH; Mahmoud AA
J Infect Public Health; 2019; 12(3):350-356. PubMed ID: 30833193
[TBL] [Abstract][Full Text] [Related]
36. Presence of acute hepatitis D infection in HBsAg positive cancer patients: A preliminary study from west Gujarat.
Patel FM; Goswami PN
Indian J Med Res; 2016 Jun; 143(6):798-800. PubMed ID: 27748305
[TBL] [Abstract][Full Text] [Related]
37. Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan.
Lu MY; Chen CT; Shih YL; Tsai PC; Hsieh MH; Huang CF; Yeh ML; Huang CI; Wang SC; Tsai YS; Ko YM; Lin CC; Chen KY; Wei YJ; Hsu PY; Hsu CT; Jang TY; Liu TW; Liang PC; Hsieh MY; Lin ZY; Chen SC; Huang JF; Dai CY; Chuang WL; Yu ML; Chang WY
Sci Rep; 2021 Apr; 11(1):8554. PubMed ID: 33879825
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Hepatitis Delta Virus Among Pregnant Women of Pakistan.
Aftab M; Naz S; Aftab B; Ali A; Rafique S; Fatima Z; Inamullah ; Idrees M
Viral Immunol; 2019 Oct; 32(8):335-340. PubMed ID: 31553269
[TBL] [Abstract][Full Text] [Related]
39. Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
Alfaiate D; Clément S; Gomes D; Goossens N; Negro F
J Hepatol; 2020 Sep; 73(3):533-539. PubMed ID: 32151618
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis delta virus and hepatocellular carcinoma: an update.
Romeo R; Petruzziello A; Pecheur EI; Facchetti F; Perbellini R; Galmozzi E; Khan NU; Di Capua L; Sabatino R; Botti G; Loquercio G
Epidemiol Infect; 2018 Oct; 146(13):1612-1618. PubMed ID: 29991359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
